Synergy is a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies. The company has pioneered discovery, research and development efforts around analogs of uroguanylin, a naturally occurring human GI peptide, for the treatment of GI diseases and disorders. Synergy’s proprietary GI platform includes one commercial product TRULANCE® (plecanatide) and a second product candidate - dolcanatide. For more information, please visit www.synergypharma.com.
Company profile
Ticker
SGYP
Exchange
Website
CEO
Troy Hamilton
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Pawfect Foods Inc, Synergy Pharmaceuticals, Inc., Synergy Pharmaceuticals, Inc.
SEC CIK
Corporate docs
IRS number
330505269
Latest filings (excl ownership)
25-NSE
Exchange delisting
2 May 19
8-K
Bankruptcy or Receivership
2 May 19
8-K
Bankruptcy or Receivership
29 Apr 19
8-K
Bankruptcy or Receivership
2 Apr 19
8-K
Bankruptcy or Receivership
14 Mar 19
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8 Mar 19
8-K
Completion of Acquisition or Disposition of Assets
6 Mar 19
8-K
Synergy Pharmaceuticals Receives Court Approval for the Sale of Its Assets to Bausch Health
1 Mar 19
8-K
Synergy Pharmaceuticals Confirms Bausch Health as Successful Bidder for Its Business Assets
27 Feb 19
8-K
Departure of Directors or Certain Officers
5 Feb 19
Latest ownership filings
SC 13G/A
Synergy Pharmaceuticals, Inc.
12 Feb 19
SC 13G/A
Synergy Pharmaceuticals, Inc.
11 Feb 19
SC 13G/A
Synergy Pharmaceuticals, Inc.
10 Jan 19
4
Melvin K Spigelman
16 Aug 18
4
THOMAS PHD ADAMS
6 Jul 18
4
JOHN P BRANCACCIO
6 Jul 18
4
Melvin K Spigelman
19 Jun 18
4
THOMAS PHD ADAMS
19 Jun 18
4
Timothy Sean Callahan
19 Jun 18
4
Alan Joslyn
19 Jun 18
Institutional ownership, Q1 2024
| 13F holders | Current |
|---|---|
| Total holders | 0 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 0.00 |
| Total shares | 0.00 |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|